DNM1L and diabetes mellitus: This may be related to the fact that Drp1 mainly undergoes changes in activation and translocation in acute diseases such as ischemic-hypoxic injury [4, 10], whereas Drp1 mainly shows increased expression in chronic diseases such as tumors and diabetes [37, 38], and these differences may have varying effects on Drp1 binding to target proteins.